Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01228903 · ClinicalTrials.gov registry record · NA
Uric Acid and the Endothelium in CKD
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT01228903: Completed NA study, sponsored by University of Colorado, Denver.
NCT01228903 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01228903, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will test the hypothesis that uric acid impairs the function of vessels in patients with kidney disease
Primary Outcome
Change in Endothelial Dependent Dilation measured by Flow Mediated Dilation at baseline and week 12
Interventions
- OTHER Placebo
- DRUG Allopurinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT01228903 record still lists
NCT01228903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01228903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01228903 about?
NCT01228903 is a clinical study titled "Uric Acid and the Endothelium in CKD". This study will test the hypothesis that uric acid impairs the function of vessels in patients with kidney disease
What is the current status of trial NCT01228903?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2010-10. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01228903?
The interventions under investigation include: Placebo (OTHER), Allopurinol (DRUG).
Who is sponsoring clinical trial NCT01228903?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01228903's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia